Oxford Nanopore Technologies
Oxford Nanopore Technologies is a UK-based company that has developed and sells a new generation of DNA/RNA sequencing technology, providing real-time, scalable, and accessible analysis of biological molecules.
Company facts
- Founded
- 2005
- Headquarters
- United Kingdom
- CEO
- Gordon Sanghera
About
We are Oxford Nanopore Technologies, and our goal is to enable the analysis of anything, by anyone, anywhere. Founded in 2005 as a spin-out from the University of Oxford, we have dedicated ourselves to developing a new generation of nanopore-based sensing technology. This technology is designed to bring the widest possible benefits to society by making DNA and RNA sequencing accessible, fast, and rich in data. Our journey began with a vision to disrupt the traditional methods of biological analysis, and today, our technology is used in over 120 countries to explore the biology of humans, plants, animals, bacteria, viruses, and entire environments. We are passionate about empowering the scientific community and beyond, providing tools that open up new frontiers in research and have a profound, positive impact on society. Our team is at the heart of our innovation. We employ over 1,000 people from a multitude of disciplines, including nanopore science, molecular biology, informatics, engineering, and manufacturing. This multidisciplinary collaboration is key to our success. We've developed a range of products, from the portable MinION to the high-throughput PromethION, all designed to be scalable and user-friendly. Our technology is unique in its ability to provide real-time analysis of native DNA or RNA, sequencing fragments of any length to deliver a comprehensive genomic picture. We are committed to continuous innovation, constantly improving our technology to enhance accuracy, ease of use, and the richness of the biological data our users can obtain. We believe in creating a future where the ability to analyze DNA and RNA in real time is available to every biologist, driving discoveries in areas from human genetics and cancer research to infectious disease surveillance and environmental science.